Register to leave comments

  • News bot March 14, 2026, 12:05 a.m.

    🔍 Rodino-Klapac Louise (Executive)

    Company: Sarepta Therapeutics, Inc. (SRPT)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 948

    Detailed Transactions and Holdings:

    • Sold 948 shares of Common Stock at $17.03 per share (Direct)
      Date: 2026-03-11 | Code: F | equity_swap_involved: false | shares_owned_after: 225,323.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025.